"Russia Pharmaceuticals & Healthcare Report Q1 2013" Is Now Available at Fast Market Research
BMI View: The Russian pharmaceutical market remains a powerhouse in the Emerging Europe region. The country has by far the largest population in the region. Its resources-driven economic growth is funding both private and public spending on medicines and healthcare services. The country's World Trade Organisation (WTO) accession has eliminated tariff barriers and should, in the long run, drive major improvements in a problematic intellectual property environment. Both domestic and cross-border mergers and acquisitions (M&A) activity has picked up since...
View full press release